Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$49.72 - $54.64 $119,676 - $131,518
-2,407 Reduced 33.21%
4,841 $261,000
Q1 2023

May 05, 2023

SELL
$45.09 - $50.03 $181,847 - $201,770
-4,033 Reduced 35.75%
7,248 $362,000
Q4 2022

Feb 09, 2023

BUY
$39.56 - $47.22 $1,384 - $1,652
35 Added 0.31%
11,281 $522,000
Q3 2022

Nov 03, 2022

BUY
$36.71 - $109.66 $10,609 - $31,691
289 Added 2.64%
11,246 $472,000
Q2 2022

Aug 05, 2022

BUY
$35.24 - $47.1 $35,627 - $47,618
1,011 Added 10.16%
10,957 $408,000
Q1 2022

May 02, 2022

BUY
$40.9 - $45.1 $406,791 - $448,564
9,946 New
9,946 $441,000
Q4 2020

Feb 11, 2021

SELL
$33.15 - $41.97 $240,602 - $304,618
-7,258 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$34.44 - $42.23 $8,231 - $10,092
239 Added 3.41%
7,258 $277,000
Q2 2020

Aug 05, 2020

BUY
$30.19 - $39.11 $19,200 - $24,873
636 Added 9.96%
7,019 $246,000
Q1 2020

May 05, 2020

BUY
$25.83 - $45.71 $4,649 - $8,227
180 Added 2.9%
6,383 $208,000
Q4 2019

Feb 03, 2020

BUY
$37.87 - $45.37 $26,243 - $31,441
693 Added 12.58%
6,203 $280,000
Q3 2019

Nov 05, 2019

BUY
$40.31 - $43.45 $222,108 - $239,409
5,510 New
5,510 $224,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $146B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Gilbert & Cook, Inc. Portfolio

Follow Gilbert & Cook, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gilbert & Cook, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gilbert & Cook, Inc. with notifications on news.